-
Laminar Pharma Announces “Last Patient, Last Visit” in LAM561 Phase 2b/3 Trial for Newly Diagnosed Glioblastoma Patients
PALMA DE MALLORCA, Spain, July 24, 2026 /PRNewswire/ — Laminar Pharma, a leader in the development of innovative therapies based on a novel membrane lipid therapy approach, today announced that the last patient has completed their last visit (LPLV) in the company’s Phase 2b/3 clinical trial of its lead asset, LAM561, in patients with newly diagnosed…
-
Apollo Hospitals Brings Next-Generation Lysin Science to India’s Fight Against AMR – Collaborates with Precisio Biotix
HYDERABAD, India, July 21, 2026 /PRNewswire/ — Apollo Hospitals today announced a strategic collaboration with Precisio Biotix to accelerate the development and clinical adoption of lysin-based antimicrobials in India – marking a significant step forward in combating antimicrobial resistance (AMR). This partnership will focus on translational research, clinical validation, and potential deployment pathways for lysin-based therapies across…
-
Hisense Unveils AI-Powered Growth Strategy to Shape the Next Era of Intelligent Living
QINGDAO, China, July 21, 2026 /PRNewswire/ — Hisense, a leading brand in global consumer electronics and home appliances, has unveiled a comprehensive AI-powered growth strategy that will guide the company’s next phase of global development, reinforcing its commitment to innovation, intelligent living and long-term customer value. This strategy was introduced during the Hisense Global Partner…
-
Allogenetics Appoints Dr. Jeroen Rovers as Chief Medical Officer
Seasoned executive leader and physician-scientist brings deep immunology and transplant medicine experience Company strengthens executive team as it advances its lead ex vivo donor-organ therapy ALG-115 toward clinical entry ALG-115 is designed to transform the treatment of graft rejection in lung transplantation Hanover, Germany, July 21, 2026 – Allogenetics today announced the appointment of Jeroen Rovers,…
-
VERAXA Biotech Announces Regulatory Progress with its BiTAC®-TCE Development Plan
ZURICH, SWITZERLAND – July 20, 2026 – VERAXA Biotech AG (NASDAQ: VRXA; “VERAXA), an emerging leader in designing novel cancer therapies, today announced that it has received Scientific Advice from the German regulatory authority, the Paul-Ehrlich-Institute (PEI), regarding the underlying biology and proposed non-clinical development plan for its most-advanced development program based on its proprietary…
-
LeafTide Announces Weight Loss Supplement Launch Focused on Quality, Transparency, and Leaf Tide Consumer Education
Largo, FL, July 19, 2026 (GLOBE NEWSWIRE) — LeafTide today announced the introduction of a new dietary supplement as part of the company’s continued efforts to develop products within the broader wellness and nutrition category. The announcement reflects the company’s focus on responsible product development, clear communication, and providing consumers with accessible information about dietary supplements.…
-
Union Minister of Finance and Corporate Affairs Inaugurates Indoor Sports Complex in Tiruchuli
The sports complex has been developed in response to an identified need highlighted by the District Rural Development Agency State-of-the-art sports facility will encourage youth and boost community fitness The project aims to benefit more than 500 students annually Union Minister for Finance and Corporate Affairs Smt. Nirmala Sitharaman inaugurated the newly constructed Indoor…
-
Cytek® Biosciences Opens New Innovation Center in Bellevue to Advance R&D and Customer Engagement
FREMONT, Calif., July 15, 2026 (GLOBE NEWSWIRE) — Spectral flow cytometry leader Cytek Biosciences, Inc. (Nasdaq: CTKB) today announced the opening of a new innovation center in Bellevue, Washington, marking the relocation of its previous Seattle-area operations to a dedicated facility designed to support research and development (R&D) while strengthening collaboration and customer engagement. The…
-
From permanent circuits to street circuits, Geely Cyan Racing secures fifth victory of the 2026 Kumho FIA TCR World Tour
VILA REAL, Portugal, July 15, 2026 /PRNewswire/ — The European rounds of the 2026 Kumho FIA TCR World Tour concluded in Vila Real, where Geely Cyan Racing secured its fifth victory of the season and took the lead in the Teams’ Championship. French driver Yann Ehrlacher won Race 1, while the other three drivers finished…
-
Xinhua Silk Road: Heilongjiang launches culture and tourism promotion event in Jixi City
BEIJING, July 14, 2026 /PRNewswire/ — A culture and tourism promotion conference kicked off in Jixi City, northeast China’s Heilongjiang Province, on July 8 as one of the events of the 8th Heilongjiang Provincial Tourism Industry Development Conference. Integrating Sushen Culture, one of the earliest fishing and hunting civilizations in northeast China, border landscapes, red cultural…
-
Assetz Announces Partnership with Rohan Bopanna Tennis Academy
Assetz, one of Bengaluru’s leading real estate developers, and Rohan Bopanna Tennis Academy (“RBTA”), India’s leading tennis development, academy, has announced a five-year partnership to support the growth of tennis culture and high-performance training ecosystems through the Academy. As an Associate Partner of RBTA, Assetz will support the Academy’s larger ecosystem, spanning its infrastructure and talent development…
-
Appili Therapeutics Announces Receipt from NIAID of a Notice of Termination for Convenience on the Contract for the VXV-01 Program
HALIFAX, Nova Scotia, July 03, 2026 (GLOBE NEWSWIRE) — Appili Therapeutics Inc. (TSX: APLI; OTCPink: APLIF) (the “Company” or “Appili”), a biopharmaceutical company focused on drug development for infectious diseases today announced that it has received a Notice of Termination for Convenience from the National Institute of Allergy and Infectious Diseases (“NIAID”), part of the…
-
AiraBreeze Announces Entry into the Portable Cooling Products Industry with Introduction of Its First Consumer Cooling Solution
London, UK, June 28, 2026 (GLOBE NEWSWIRE) — AiraBreeze today announced its entry into the portable cooling products industry through the introduction of its first consumer cooling solution following the completion of its initial product development phase. The announcement marks the company’s transition from product design and development into commercial operations as it begins offering…
-
Appili Therapeutics Reports Fiscal Year 2026 Financial and Operational Results
LIKMEZ® (ATI-1501) commercial momentum building in U.S. market US$40 million NIAID award supporting VXV-01 advancement through Phase 1 HALIFAX, Nova Scotia, June 26, 2026 (GLOBE NEWSWIRE) — Appili Therapeutics Inc. (TSX:APLI; OTCPink: APLIF) (the “Company” or “Appili”), a biopharmaceutical company focused on drug development for infectious diseases and medical countermeasures, today announced its financial and…
-
Central Park Bangkok Wins Top Retail Asia Award, Reinforcing Its Position as Bangkok’s New World-Class Landmark
BANGKOK, June 25, 2026 /PRNewswire/ — Rising above the Bangkok skyline and redefining urban living in the heart of the Thai capital, Central Park has rapidly emerged as one of the city’s most significant new destinations, bringing together world-class dining, curated brands, green public space, lifestyle experiences, and seamless connectivity in a single landmark development.…
-
Xinhua Silk Road: Global estate representatives gather at Langjiu to explore inheritance, innovation
BEIJING, June 24, 2026 /PRNewswire/ — When the Estate Culture Forum (Chishui River Baijiu Region) kicked off at Langjiu Estate in Sichuan, southwest China recently, global estate experts gathered to explore ways to achieve development-oriented innovation through inheritance to navigate market cycles. Currently, inheritance and innovation are the core issues facing global liquor brands, said…
-
Coherus and Zumutor Biologics Announce Clinical Collaboration to Evaluate ZM008 in Combination with LOQTORZI® (toripalimab-tpzi)
– First patient dosed in a Phase 1 study evaluating ZM008, an anti-LLT1 mAb, in combination with LOQTORZI, a next-generation PD-1 inhibitor – June 23, 2026 14:00 ET | Source: Coherus Oncology, Inc. REDWOOD CITY, Calif., June 23, 2026 (GLOBE NEWSWIRE) — Coherus Oncology, Inc. (Nasdaq: CHRS) and Zumutor Biologics Inc. (“Zumutor”), an immuno-oncology biotech…
-
Piramal Pharma Solutions Highlights Strong Performance Across More Than 200 Customer Audits
Piramal Pharma Solutions completed more than 200 customer audits and received over 70 approvals from regulatory agencies across its global network over the past year, with strong overall outcomes. This milestone reflects the Company’s long-range quality strategy focused on sustained compliance, continuous audit readiness, and operational effectiveness. Through robust governance, quality culture initiatives, workforce development, and…
-
Resolution Therapeutics extends inflammatory and fibrotic disease pipeline with in vivo Regenerative Macrophage Therapy
Material Transfer Agreements provide access to leading lipid nanoparticle formulations to validate delivery of its proprietary payloads and accelerate development of in vivo Regenerative Macrophage Therapy Development programme complements Company’s autologous engineered Regenerative Macrophage Therapy, RTX001, in Ph 1/2 clinical development Together, programmes aim to broaden patient population able to benefit from Regenerative Macrophage Therapy…
-
Maiva Pharma Inaugurates New State-of-the-Art Sterile Injectable Manufacturing Facility at Shoolagiri, India
Six manufacturing lines to enable production of diverse sterile injectable formats, from vials and pre-filled syringes to cartridges, suspensions and lyophilized formulations Bengaluru, Karnataka, India Maiva Pharma, a leading global Contract Manufacturing Organization (CMO) and Contract Development and Manufacturing Organization (CDMO) specialising in sterile injectables, today inaugurated its new manufacturing facility at Shoolagiri, Tamil Nadu,…
-
ARCPOINT ANNOUNCES APPOINTMENT OF PETER KENDALL AS INTERIM CHIEF EXECUTIVE OFFICER
June 09, 2026 19:00 ET | Source: ARCpoint Inc. GREENVILLE, South Carolina, June 09, 2026 (GLOBE NEWSWIRE) — ARCpoint Inc. (TSXV: ARC) (the “Company” or “ARCpoint”) announces that its Board of Directors has appointed Peter Kendall as Interim Chief Executive Officer of the Company, effective June 9, 2026. Mr. Kendall’s appointment remains subject to acceptance…
-
BBBS & Israel's Foresight Awarded USD 5 Million to Build & Commercialize Rugged Autonomous Drones for Hazardous Industrial Environments
Big Bang Boom Solutions Pvt. Ltd. (BBBS), a leading Indian DeepTech startup, today announced the formal approval of a $5 million joint research, development, and commercialization project with Israel-based Foresight Autonomous Holdings Ltd. (Nasdaq and TASE: FRSX). The project, funded under the India-Israel Industrial R&D and Technological Innovation Fund (I4F), will focus on developing rugged…
-
India's Defence Triumph in Operation Sindoor Showcases the Power of DRDO Indigenous Collaboration
Operation Sindoor has come to symbolize more than just a successful military campaign—it represents India’s emerging confidence in its own defence ecosystem, powered by years of innovation, foresight, and collaborative development. At the centre of this transformative moment stands the Defence Research and Development Organisation (DRDO), whose ability to translate research into deployable combat systems…
-
Earth One at Igatpuri Hills Announces Dr. Mickey Mehta as Holistic Living Ambassador
MUMBAI, India, Feb. 9, 2026 /PRNewswire/ — Earth One at Igatpuri Hills, a premium 50-acre gated plotted development nestled in the Western Ghats, has announced its association with global leading holistic health guru, Dr. Mickey Mehta as the Holistic Living Ambassador for the project. This association brings together Earth One’s vision of conscious, community-centric living with Dr.…
-
Akums Reports Q2 FY26 Results; Strengthens International Presence
New Delhi, Delhi, India Akums Drugs & Pharmaceuticals Ltd., India’s Largest Contract Development and Manufacturing Organizations (CDMO), announced its financial results for the second quarter of FY26. The CDMO segment remained the key contributor with revenue of Rs. 804 crore. Volumes for the CDMO vertical grew 7% y-o-y, as against muted industry volume growth, reflecting…
-
Healthcare experts call for bold national action to tackle children’s inactivity crisis
The Class of 2035 Commission warns children’s inactivity levels – driving rising anxiety, poor development and chronic conditions – are at a tipping point The Class of 2035 Commission, convened by Youth Sport Trust and bringing together leading voices from across healthcare to address growing challenges in children’s health and wellbeing, has today published its…
-
WaveMaker Fuses Design and Development with Architecture-first Agentic Application Generation System for Enterprise Dev Teams
Brings deterministic outcomes and low, predictable costs to AI-assisted development for businesses Bengaluru, Karnataka, India; Plano, Texas , United States WaveMaker, a leading application platform provider for enterprise-grade web and mobile applications, today announced the availability of its new agentic application generation system, designed to target a growing need for a standardized AI-powered development model…
-
From Pilots to Impact: Pre-AI Summit Pushes Scalable AI for Indian Agriculture
New Delhi, Delhi, India MicroSave Consulting (MSC) convened a high-level pre-summit event in New Delhi focused on practical pathways to scale climate-resilient agriculture using artificial intelligence (AI) anchored in Digital Public Infrastructure (DPI). The discussion brought together policymakers, development partners, technology leaders, and practitioners to move from fragmented pilots to sustained public delivery at scale.…
-
Alvotech announces resubmission of U.S. Biologics License Applications for AVT05, a proposed biosimilar to Simponi® and Simponi Aria®, and AVT06, a proposed biosimilar to Eylea®
REYKJAVIK, Iceland, June 4, 2026 – Alvotech (NASDAQ: ALVO; ALVO-SDB), a global biotechnology company specializing in the development and manufacture of biosimilar medicines for patients worldwide, today announced the resubmission to the U.S. Food and Drug Administration (FDA) of Biologics License Applications (BLAs) for AVT05, a proposed biosimilar to Simponi® and Simponi Aria® (golimumab), and AVT06,…
-
Sword Group: Strategic contract with eu-LISA
Sword Group | eu-LISA framework contract awarded to leading consortium Sword ranked first in a €93 million contract for the EU Entry/Exit System Sword Services Greece, leading a consortium alongside Netcompany and Sopra Steria, has been ranked first and awarded a contract under eu-LISA’s Dynamic Purchasing System for the development and maintenance of the Entry/Exit…
-
Nicole Junkermann Led Gameday Targets India, Plans Sports Technology Expansion
Gameday by NJF Holdings, the sports investment and technology platform founded by international investor Nicole Junkermann, today announced the expansion of its sports technology platform into India, identifying the country’s professional leagues as a priority market for digital infrastructure development. The move signals Gameday’s view that India’s sports economy has reached an inflection point:…
-
Morepen Bags Rs. 825 Crore Global Deal
Morepen Laboratories Limited (NSE: MOREPENLAB; BSE: 500288) has secured a multi-year Contract Development and Manufacturing Organization (CDMO) mandate valued at approximately Rs. 825 crore (USD 91 million) from a leading global pharma major. Morepen Bags Rs. 825 Crore Global Deal, Expands into High-Growth CDMO Segment Supplies under the mandate are expected to commence within the…
-
Akums Delivers Strong Q3 FY26 Performance with 14.8% Revenue Growth and 21% Adj EBITDA Growth
New Delhi, Delhi, India Akums Drugs & Pharmaceuticals Ltd., India’s Largest Contract Development and Manufacturing Organizations (CDMO), announced its financial results for the third quarter of FY26. Q3 FY 26 saw strong performance across its key business segments. CDMO saw a revenue growth of over 16% spurred on by double digit increase in volumes. The…
-
Dudigital Global Limited Secures CPV Services Contract from Embassy of India, Kuwait
3-year contract strengthens recurring revenue visibility and expands GCC presence New Delhi, Delhi, India Dudigital Global Limited today announced that it has been awarded the contract for outsourcing of Consular, Passport and Visa services by the Embassy of India, Kuwait, following a two-stage competitive bidding process. The contract is valid for a period of three…
-
J-Star Holding Provides Additional Details on Baytown Economic Development Foundation LOI Supporting Proposed U.S. Solid-State Battery Manufacturing Facility
Formal LOI Details Site Selection Support, Infrastructure Requirements, 18-Month Site Availability Commitment, and Framework for Long-Term Facility Development June 01, 2026 11:50 ET | Source: J-Star Holding Co., Ltd TAICHUNG CITY, Taiwan, June 01, 2026 (GLOBE NEWSWIRE) — J-Star Holding Co., Ltd. (Nasdaq: YMAT) (“J-Star” or the “Company”), today provided additional details regarding the commitment…
-
Akums Reports Q4 FY26 and Full Year FY26 Results with Healthy Top Line and Strong EBITDA Growth; Board Recommends Dividend
New Delhi, Delhi, India Akums Drugs & Pharmaceuticals Ltd., India’s largest Contract Development and Manufacturing Organisation (CDMO), announced its financial results for the fourth quarter and the full year ended March 31, 2026. The company delivered a steady performance during Q4 FY26, with healthy revenue growth and improved operating profitability driven by its core domestic…
-
Strategic Partnerships Driving the Dialogue at Kalam & Kavach 3.0
As India advances reforms in joint military structures and accelerates indigenous capability development, Kalam & Kavach 3.0 returns on 14 May 2026 at the Manekshaw Centre, bringing together the country’s top military leadership, policymakers, and defence industry stakeholders. The upcoming edition comes as India accelerates theatre command reforms, expands indigenous manufacturing, and strengthens its posture…
-
XCMG Secures Over $1 Billion in Orders at 8th International Customer Festival, Expanding Global Partnerships
XUZHOU, China, May 29, 2026 /PRNewswire/ — XCMG concluded its 8th International Customer Festival, held from May 19 to 23 in Xuzhou, with more than 2,500 customers and business partners from around the world in attendance. During the event, signed orders exceeded US$1 billion, setting a new record for XCMG’s International Customer Festival and reflecting…
Latest News
About the Author
We increase the awareness of millions of users through our news networks. We are one of the most trusted news networks in the world.